SGCB and pulmonary arterial hypertension: The sGC represents a druggable target and sGC stimulators are used in different clinical scenarios, for example, riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension18 or vericiguat in chronic heart failure19.